Mergers and acquisitions among pharmaceutical companies has kicked into high gear this year, mirroring the larger trend sweeping across the entire spectrum of the health care industry since the implementation of the Affordable Care Act two years ago.
The complex issue of prescription drug abuse and access are not receiving the comprehensive approach that they deserve and greater collaboration is needed among all stakeholders to help find solutions. That was a key message that National Association of Chain Drug Stores CEO Steve Anderson and U.S. Pain Foundation president Paul Gileno shared in a joint op-ed published Tuesday in The Tampa Tribune.
In lead-up to Thursday’s Senate Finance Committee hearing, “A Pathway to Improving Care for Medicare Patients with Chronic Conditions,” the National Association of Chain Drug Stores submitted comments highlighting pharmacy’s role in helping patients manage their chronic conditions.